NEXT Oncology
Joseph Lavela, M.P.H. is currently working as a Protocol Navigator at NEXT Oncology. Previously, they have held positions such as Clinical Trial Manager at Oklahoma City Clinical Research Center, Country Approval Specialist at PPD, and Study Manager at Johnson & Johnson. They have also worked as a Protocol Navigator at The National Institutes of Health and as a Clinical Research Coordinator at Howard University College of Medicine. Joseph holds a Master of Public Health degree from Morgan State University, a Bachelor's degree in Psychology from the University of Maryland, and an Associate of Arts degree from Montgomery College.
This person is not in any offices
NEXT Oncology
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.